SINHA UMA (Chief Scientific Officer) sold 1.6% of their position (5K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $450.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/4/2020ACC: 0000899243-20-032771
Officer· Chief Scientific Officer
Since Nov 2018
-5K
Net shares
Net seller
$450.2K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
5K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−3.80K
Price / share
$89.63
Trade value
$340.40K
% of position
1.2%
12/2/2020
321.52K→317.73K
Common Stock
Direct
Shares
−702.00
Price / share
$90.63
Trade value
$63.62K
% of position
0.2%
12/2/2020
317.73K→317.02K
Common Stock
Direct
Shares
−300.00
Price / share
$91.89
Trade value
$27.57K
% of position
0.1%
12/2/2020
317.02K→316.73K
Common Stock
Direct
Shares
−200.00
Price / share
$92.97
Trade value
$18.59K
% of position
0.1%
12/2/2020
316.73K→316.52K
Total
Net shares
−5K
Net value
-$450.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2020 | S · Sale | −3.80K | $89.63 | $340.40K | 1.2% | 321.52K | 317.73K |
| Common Stock Direct | 12/2/2020 | S · Sale | −702.00 | $90.63 | $63.62K | 0.2% | 317.73K | 317.02K |
| Common Stock Direct | 12/2/2020 | S · Sale | −300.00 | $91.89 | $27.57K | 0.1% | 317.02K | 316.73K |
| Common Stock Direct | 12/2/2020 | S · Sale | −200.00 | $92.97 | $18.59K | 0.1% | 316.73K | 316.52K |
| Total | −5K | -$450.19K | ||||||
Derivative Transactions0
No derivative transactions reported